Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus brevis SBC8803 and Improved Intestinal Barrier Function

Research synthesisVery low evidenceModerate effect5 studies · 5 beneficial · 0 neutral · 0 harmful

Across 5 studies in the database, all 5 reported beneficial effects of Lactobacillus brevis SBC8803 on improved intestinal barrier function. The predominant effect size was moderate, though none of the studies reported statistically significant findings. Doses and populations varied widely across studies, with two studies using cell-free supernatants in Caco-2 cell models and mouse models, and three being narrative reviews without specific dose or population data.

Caveats: All studies are either narrative reviews or early-stage experiments (cell lines and animal models) with no human trials. None of the studies reported statistical significance, and direct evidence specific to the strain Lactobacillus brevis SBC8803 is minimal — many studies examined other probiotic strains or general mechanisms.

Generated May 11, 2026
8 of 8 papers
Back to top